DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20184049

Pattern of extra pulmonary tuberculosis among urban population with special reference to CBNAAT as a diagnostic tool: a retrospective study at a tertiary care hospital of Odisha, India

C. Mohan Rao, Bhaskar Thakur, Saswat Subhankar, D. P. Dash

Abstract


Background: Diagnosis of Extra-pulmonary TB (EPTB) is a challenge. Authors wanted to assess the sites of extra-pulmonary involvement during 2013-2017 in a tertiary care hospital cum medical college. Authors also wanted to evaluate the role of Cartridge Based Nucleic Acid Amplification Test (CBNAAT) in diagnosis of EPTB and compare its efficacy with AFB Culture.

Methods: Total 470 EPTB cases diagnosed between 2013 and 2017 from 840 TB treatment records maintained in designated microscopy centre. Specific samples from appropriate sites were taken up for smear for AFB, CBNAAT and AFB culture.

Results: There was incremental detection and registration in both TB and EPTB cases from 96 and 50 cases in 2013 to 246 and 150 cases in 2017 respectively. Among the total 470 EPTB cases in 2013-2017 (55.9%), lymph node followed by pleura and abdomen were the organs having maximum involvement. Bone involvement was more witnessed in adult male than children (p <0.05). There was male preponderance. CBNAAT results were 100 % sensitive and 87.5% specific. Lymph node samples and pus elsewhere in the body had much better diagnostic yield than serous effusions.

Conclusions: Awareness and availability of diagnostic services in tertiary care institutions has lead to increased reporting of EPTB under RNTCP services. CBNAAT can be also be utilized as a point of care testing for lymph node aspirate and pus specimen.


Keywords


CBNAAT, EPTB, RNTCP

Full Text:

PDF

References


Olson NA, Davidow AL, Winston CA, Chen MP, Gazmararian JA, Katz DJ. A national study of socioeconomic status and tuberculosis rates by country of birth, United States, 1996-2005. BMC Public Health. 2012 Dec;12(1):365.

Government of India. The National Tribal Policy (Draft). A Policy for the Scheduled Tribes of India; 2006. Available at: http://www.legalpundits.com?content folder/tribalpolicy.pdf.

Basu SK. A health profile of tribal India. Health Millions. 1994 Apr 1;2(2):12-4.

WHO global tuberculosis report; 2016. Available at: http://www.who.int/tb/publications/global_report/en/.

TB India 2017. RNTCP status Report. Central TB division, Directorate General of Health Services, Ministry of Health and Family Welfare, Nirman Bawan, New Delhi; 2017.

WHO. Tuberculosis Control in South East Asia Region, Regional Report; 2016.

Arora VK, Gupta R. Directly observed treatment for tuberculosis. Indian J Paedtr. 2003;70:885-9.

Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician. 2005 Nov 1;72(9):1761-8.

Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infectious Dis. 2013 Apr 1;13(4):349-61.

Sharma SK, Ryan H, Khaparde S, Sachdeva KS, Singh AD, Mohan A, et al. Index-TB Guidelines: Guidelines on extrapulmonary tuberculosis for India. Indian J Med Res. 2017 Apr;145(4):448.

Pandit S, Dey A, Chaudhuri AD, Saha M, Sengupta A, Kundu S, et al. Five-years experiences of the revised national tuberculosis control programme in northern part of Kolkata, India. Lung India: official organ of Indian Chest Society. 2009 Oct;26(4):109.

Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberculosis Lung Dis. 2003 Dec 1;7(12):1178-85.

Sunnetcioglu A, Sunnetcioglu M, Binici I, Baran AI, Karahocagil MK, Saydan MR. Comparative analysis of pulmonary and extrapulmonary tuberculosis of 411 cases. Ann Clin Microbiol Antimicrob. 2015 Dec;14(1):34.

Tahir M, Sharma SK, Rohrberg DS, Gupta D, Singh UB, Sinha PK. DOTS at a tertiary care center in northern India: successes, challenges and the next steps in tuberculosis control. Indian J Med Res. 2006 May 1;123(5):702.

Maltezou HC, Spyridis P, Kafetzis DA. Extrapulmonary tuberculosis in children. Arch Dis Child. 2000;83:342-6.

Prakasha SR, Suresh G, D’sa IP, Shetty SS, Kumar SG. Mapping the pattern and trends of extrapulmonary tuberculosis. J Global Infect Dis. 2013 Apr;5(2):54.

Mavila R, Kottarath M, Nair S, Thaha MM. Site predilection of extrapulmonary tuberculosis: study from a tertiary care centre. Int J Res Med Sci. 2017 Jan 16;3(11):3386-90.

Ilgazli A, Boyaci H, Basyigit İ, Yildiz F. Extrapulmonary tuberculosis: clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004 Sep 10;35(5):435-41.

Berger HW, Mejia E. Tuberculosis Pleurisy. Chest. 1973;63(1):88-92.

Scharer L, McClement JH. Isolation of tubercle bacilli from needle biopsy specimens of parietal pleura. Am Rev Respir Dis. 1968;97(3):466-8.

Detjen AK, DiNardo AR, Leyden J, Steingart KR, Menzies D, Schiller I, et al. Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Resp Med. 2015 Jun 1;3(6):451-61.

Lawn SD, Zumla AI. Diagnosis of extrapulmonary tuberculosis using the Xpert® MTB/RIF assay. Expert Rev Anti Infect Ther. 2012;10(6):631-5.